awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26827319-33C1C94D-A25F-4F2C-AE94-4F593B41D546
Q26827319-33C1C94D-A25F-4F2C-AE94-4F593B41D546
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26827319-33C1C94D-A25F-4F2C-AE94-4F593B41D546
Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma
P2860
Q26827319-33C1C94D-A25F-4F2C-AE94-4F593B41D546
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26827319-33C1C94D-A25F-4F2C-AE94-4F593B41D546
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f84e3244d92ba8759d2d838bc2df32ab48f75f2b
P2860
Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial.